Dual Antiplatelet Therapy with Parenteral P2Y<sub>12</sub> Inhibitors: Rationale, Evidence, and Future Directions.

Alagna, Giulia; Mazzone, Paolo; Contarini, Marco; Andò, Giuseppe

Dual Antiplatelet Therapy with Parenteral P2Y₁₂ Inhibitors: Rationale, Evidence, and Future Directions.

Alagna, Giulia; Mazzone, Paolo; Contarini, Marco; Andò, Giuseppe.

Afiliación

Alagna G; Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.
Mazzone P; Cardiology Unit, "Umberto I" Hospital, 96100 Siracusa, Italy.
Contarini M; Cardiology Unit, "Umberto I" Hospital, 96100 Siracusa, Italy.
Andò G; Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.

J Cardiovasc Dev Dis ; 10(4)2023 Apr 09.

Article en En | MEDLINE | ID: mdl-37103042

Palabras clave

P2Y12 inhibitors; acute coronary syndrome; cangrelor; clopidogrel; dual antiplatelet therapy; prasugrel; selatogrel; ticagrelor; zalunfiban

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Cardiovasc Dev Dis Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google